Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 27.80
Ask: 28.00
Change: 0.40 (1.45%)
Spread: 0.20 (0.719%)
Open: 28.50
High: 28.70
Low: 27.80
Prev. Close: 27.60
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dimensional Fund Advisors Ltd. : Form 8.3 - MARSTON'S PLC - Ordinary Shares

8 Feb 2021 11:14

Dimensional Fund Advisors Ltd. : Form 8.3 - MARSTON'S PLC - Ordinary Shares

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Marston’s plc(GB00B1JQDM80)
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 5 February 2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” N/A If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:  7.375p Ordinary Shares
 Interests Short positions
 Number % Number %
(1) Relevant securities owned and/or controlled: 31,546,079* 4.98%    
(2) Cash-settled derivatives:         
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:        
TOTAL: 31,546,079 4.98%    

*Dimensional Fund Advisors Ltd. and / or its affiliates do not control voting discretion for 1,067,742 shares.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale  Number of securities Price per unit
Ordinary shares Sale 119,633 GBP 0.9927

 (b) Cash-settled derivative transactions

Class of relevant security Product descriptione.g. CFD Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
         

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Typee.g. American, Eropean etc. Expiry date Option money paid/ received per unit
               

(ii) Exercise

Class of relevant security Product descriptione.g. call option Exercising/ exercised against Number of securities Exercise price per unit
         

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealinge.g. subscription, conversion Details Price per unit (if applicable)
       

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO

Date of disclosure: 8 February 2021
Contact name: Thomas Hone
Telephone number: 020 3033 3419

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
1st Feb 202112:00 pmRNSForm 8.5 (EPT/RI) Martson's Plc
1st Feb 202111:47 amRNSForm 8.5 (EPT/RI)- Marston’s plc
1st Feb 202111:41 amRNSForm 8.3 - Marston's plc
1st Feb 202111:34 amRNSForm 8.3 - Marston's PLC
1st Feb 20217:00 amRNSRule 2.9 Announcement
29th Jan 20215:56 pmRNSForm 8.3 - [Marston's PLC]
29th Jan 20214:59 pmRNSRule 2.9 Announcement
29th Jan 202112:25 pmRNSForm 8.3 - Marston's PLC
29th Jan 202111:24 amRNSStatement regarding press speculation
27th Jan 202110:21 amRNSResult of AGM
12th Jan 20218:25 amRNSBlock listing Interim Review
8th Jan 20217:00 amRNSQ1 Update
24th Dec 202012:07 pmRNSAnnual Financial Report
23rd Dec 20207:00 amRNSMarston’s PLC to operate SA Brain pub estate
10th Dec 20207:00 amRNSRESULTS FOR THE 53 WEEKS ENDED 3 OCTOBER 2020
3rd Dec 202010:34 amRNSCOVID-19 Update: Result Noteholder Consent Request
11th Nov 20208:10 amRNSCOVID-19 Update re: Noteholder Consent Request
30th Oct 20202:41 pmRNSCompletion of brewing JV with Carlsberg UK
15th Oct 20207:00 amRNSYear End Trading Update
13th Oct 202011:14 amRNSNotice of Trading Update Announcement Revised Date
9th Oct 20207:09 amRNSCMA CLEARANCE OF JOINT VENTURE WITH CARLSBERG
1st Oct 20207:00 amRNSNotification of Trading Update Announcement Date
22nd Sep 202012:46 pmRNSHolding(s) in Company
7th Aug 20208:00 amRNSAppointment of Joint Corporate Broker
23rd Jul 202012:00 pmRNSTransaction Update
10th Jul 20209:03 amRNSBlock listing Interim Review
2nd Jul 20207:00 amRNSDirector/PDMR Shareholding
29th Jun 20202:30 pmRNSDirector/PDMR Shareholding
29th Jun 20201:36 pmRNSDirector Declaration
29th Jun 20209:27 amRNSDirector/PDMR Shareholding
26th Jun 20207:00 amRNSInterim Results
25th Jun 20209:23 amRNSResult of Meeting
9th Jun 202010:36 amRNSNotice of Results
8th Jun 202011:48 amRNSPublication of Circular and Notice of GM
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
29th May 202010:47 amRNSCOVID-19 Update Results Noteholder Consent Request
22nd May 20204:35 pmRNSPrice Monitoring Extension
22nd May 20201:35 pmRNSMarston’s and Carlsberg UK form JV Partnership
14th May 20207:00 amRNSCOVID-19 Financing and Dividend Update
7th May 202012:57 pmRNSCOVID-19 Update re: Noteholder Consent Request
4th May 202012:12 pmRNSChange to Interim Results Announcement Date
20th Apr 20207:00 amRNSCOVID-19 Update re: securitisation waiver granted
18th Mar 20207:00 amRNSCOVID-19 Update
17th Mar 202012:07 pmRNSSecond Price Monitoring Extn
17th Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Feb 202012:51 pmRNSTotal Voting Rights
27th Jan 202010:19 amRNSResult of AGM
24th Jan 20207:00 amRNSTrading Update
10th Jan 20209:20 amRNSBlock listing Interim Review
2nd Jan 202011:43 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.